M 350 (Metformin Extended Release 750 mg)

Pill imprint M 350 has been identified as Metformin hydrochloride extended release 750 mg.

Metformin is used in the treatment of polycystic ovary syndrome; diabetes, type 2; insulin resistance syndrome; female infertility and belongs to the drug class non-sulfonylureas. There is no proven risk in humans during pregnancy. Metformin 750 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for M 350

Metformin hydrochloride extended release 750 mg M 350
Metformin hydrochloride extended release 750 mg M 350
Metformin hydrochloride extended release 750 mg M 350
Metformin hydrochloride extended release
Imprint:
M 350
Strength:
750 mg
Color:
Tan
Size:
21.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Non-sulfonylureas
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-0350
Inactive Ingredients:
carnauba wax
silicon dioxide
magnesium stearate
polyethylene glycol
stearic acid

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)